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nant (first trimester) with left calf tenderness. This was found on
contrast venography to be secondary to a deep venous thrombo-
sis and the patient treated with heparin. Following pregnancy the
patient was given Warfarin and remained anti-coagulated. How-
ever her requirement for Warfarin continued to rise over the sub-
sequent 12 months.
An auto-antibody screen was performed which showed a pos-
itive anti-DNA antibody titre at a titre of greater than 100. There
were no double-stranded DNA antibodies though anticardiolipin
antibody titre was greater than 1 in 120 rising to a titre of 1 in 274
over 12 months.
A family history revealed a maternal great aunt who had died
of pulmonary embolism during pregnancy and a female maternal
cousin who had also presented with a deep venous thrombosis
during pregnancy.
At the end of her pregnancy the patients blood pressure be-
gan to rise and she appeared to be developing pre-eclampsia.
Delivery was induced and four days after being delivered of a
healthy infant, the patient suffered a series of epileptiform convul-
sions. An MRI was performed but this was unremarkable, howev-
er a Tc-99m HMPAO study (Figure 1) was performed which showed
multiple defects in perfusion throughout the cerebral hemispheres
consistent with multiple small infarcts.
Her circulating platelet count began to fall, and she devel-
oped both liver and renal impairment consistent with a HELLP
syndrome. To reduce the level of anti-cardiolipin antibodies plas-
ma exchange was initiated, but during treatment the patient de-
veloped chest pain and dyspnoea. Ventilation/perfusion lung scan-
ning revealed multiple perfusion defects on the Tc-99m MAA scan
but a normal Kr-81m ventilation scan consistent with multiple pul-
monary emboli (Figure 2).
Discussion
This case illustrates the flexibility of nuclear medicine techniques
in being able to identify different sites of vascular occlusion. Te-
99m HMPAO brain perfusion SPECT can be used to identify the
small infarcts which occur within the brains of patients with HELLP
syndrome -the use of anatomical methodologies such as CT has
been described (6). However in our patient, defects consistent
with multiple small brain infarcts were only seen on Tc-99m HM-
PAO imaging but not with MRI.
The condition itself is rare and affects about 1 in 15,000 live
births, it is less common in Caucasians than other racial groups
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Abstract
Patients with multi-organ disorders may present with a plethora
of confusing symptoms and signs. Often early diagnosis of sig-
nificant disease is essential and can be difficult with standard
radiological techniques. This case report presents the use of
two radioisotopic techniques to assess brain and lung perfu-
sion in a patient with such an acute-multi-organ disorder - the
HELLP syndrome.
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Introduction
Brain perfusion imaging using Tc-99m hexamethylpropyleneam-
ine-oxine (HMPAO) has been used in a variety of clinical condi-
tions (1-3). It is of particular use when infarcts are small and may
be missed on X-ray computed tomography (CT). Such diffuse
micro vascular disease may be seen in patients with multi-infarct
dementia (4) but is rarely seen in younger people unless they have
an underlying cause for microangiopathy. In some cases this may
be combined with a syndrome which results in widespread em-
boli. Such a condition, normally occurring at the end of first preg-
nancy, is the recently described Haemolysis-Elevated Liver enzyme-
Low Platelet count (HELLP) syndrome (5). In this, we demonstrate
the use of radioisotopic techniques to investigate both micro-an-
giopathic infarcts in the brain and major vessel emboli in the lungs
using standard lung and brain perfusion imaging methods.
Case report
31-year-old white Caucasian patient with an initial clinical diagno-
sis of system lupus erythematosis presented aged 31 when preg-
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Figure 1. With brain imaging the normal MRI (Figure 1a) contrasts with the small defects seen in the cortex on Tc-99m HMPAO brain
perfusion SPECT displayed as transaxial slices (Figure 1b) and as a 3D surface rendered image (Figure 1c).
Figure 2. Tc-99m MAA and Kr-81m lung scintigraphy showing a significant ventilation/perfusion mismatch in the right lung base (ventilation films marked
vent and perfusion films marked pert, anterior images are in upper row and posterior images in the lower row).
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(7). Treatment in these patients often proves difficult with repeat-
ed emboli occurring (8). As in the patient reported here, there is
evidence of a familial predisposition to the HELLP syndrome with
either the frank syndrome appearing within families or other family
members having a history of multiple emboli. At present it is un-
clear whether this family link operates through the expression of
anti-phospholipid antibodies or the anti-cardiolipin antibodies
present in our patient (9).
As this condition is a multi-organ disorder it is surprising that
there have not been other reports of the use of imaging. The only
reported use of nuclear medicine has been to assess the degree of
hepatic impairment using hepatobiliary scintigraphy and Tc-99m
sulphur colloid imaging (1011).
The distinct features of this case are not only the first reported
use of both Tc-99m HMPAO and radionuclide ventilation perfusion
lung imaging in a patient with the HELLP syndrome but also to
emphasise the enhanced sensitivity and versatility of radionuclide
techniques in patients such as this who have acute multi-organ
disease.
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